stdClass::__set_state(array( 'id' => '6227764', 'url' => 'FR/sponsor_investigator', 'image' => '', 'title' => 'Sponsor-investigateur', 'tags' => array ( 0 => 'Sponsor-investigateur', 1 => 'Medical devices', 2 => 'Pharmaceutical', 3 => 'Clinical trials', 4 => 'National Library of Medicine', 5 => '', ), 'term' => 'Sponsor-investigateur', 'source_id' => 4010894, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Medical devices', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'company' => array ( 0 => 'National Library of Medicine', ), 'lastedit' => '20150722105912', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'La personne qui initie et conduit l\'étude clinique.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507393851745107968, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Company' => 'National Library of Medicine', 'Definition' => 'The person who both initiates and conducts the clinical study.', 'Industry' => 'Medical devices; Pharmaceutical', 'Part of Speech' => 'noun', 'Product Category' => 'Clinical trials', 'Creation User' => 'elighy', 'Creation Date' => '2012/10/13', 'Term' => 'sponsor investigator', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'sponsor_investigator', ))

stdClass::__set_state(array( 'id' => '7745836', 'url' => 'FR/informed_consent_₇', 'image' => '', 'title' => 'Consentement éclairé', 'tags' => array ( 0 => 'Consentement éclairé', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Consentement éclairé', 'source_id' => 1259720, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20150721084111', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Un processus afin de s\'assurer que les patients volontaires comprennent tous les risques associés à la participation à un essai clinique tels que les effets indésirables et choisissent de participer sans coercition ni pression de quiconque. Le chercheur principal ou de ses associés sont tenus d\'expliquer l\'étude attentivement et répondre à toutes les questions d\'un participant avant l\'essai clinique.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507294573052821505, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Term' => 'informed consent', 'Definition' => 'A process to ensure that patient volunteers understand all the risks associated participating in a clinical trial such as adverse side effects and are choosing to participate without coercion or pressure from anyone. The principal investigator or his or her associates are required to explain the study carefully and answer all questions of a participant before the clinical trial.', 'Part of Speech' => 'noun', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Creation User' => 'John Martin', 'Creation Date' => '2011/5/16', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'informed_consent_₇', ))

stdClass::__set_state(array( 'id' => '6227765', 'url' => 'FR/inclusion_criteria', 'image' => '', 'title' => 'Critères d\'inclusion', 'tags' => array ( 0 => 'Critères d\'inclusion', 1 => 'Medical devices', 2 => 'Pharmaceutical', 3 => 'Clinical trials', 4 => 'National Library of Medicine', 5 => '', ), 'term' => 'Critères d\'inclusion', 'source_id' => 4010895, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Medical devices', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'company' => array ( 0 => 'National Library of Medicine', ), 'lastedit' => '20150722105913', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Les facteurs ou les raisons qui autorisent une personne à participer à une étude clinique.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507393851745107969, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Company' => 'National Library of Medicine', 'Definition' => 'The factors or reasons that allow a person to participate in a clinical study.', 'Industry' => 'Medical devices; Pharmaceutical', 'Part of Speech' => 'noun', 'Product Category' => 'Clinical trials', 'Creation User' => 'elighy', 'Creation Date' => '2012/10/13', 'Term' => 'inclusion criteria', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'inclusion_criteria', ))

stdClass::__set_state(array( 'id' => '6230217', 'url' => 'FR/investigational_new_drug_₁', 'image' => '', 'title' => 'Nouveau médicament expérimental', 'tags' => array ( 0 => 'Nouveau médicament expérimental', 1 => 'Medical devices', 2 => 'Pharmaceutical', 3 => 'Clinical trials', 4 => 'National Library of Medicine', 5 => '', ), 'term' => 'Nouveau médicament expérimental', 'source_id' => 4011789, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Medical devices', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'company' => array ( 0 => 'National Library of Medicine', ), 'lastedit' => '20150727104715', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Un médicament ou produit biologique qui est utilisé dans un essai clinique, mais pas approuvé par la FDA (soit le médicament n\'est pas disponible pour la prescription par un médecin, soit il est disponible, mais pas approuvé par la FDA pour l\'utilisation en cours d\'étude).', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507846081755480066, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Company' => 'National Library of Medicine', 'Definition' => 'A drug, or biological product that is used in a clinical trial but has not been approved by the FDA (the drug is either not available for a doctor to prescribe or, is available, but not approved by the FDA for the use being studied).', 'Industry' => 'Medical devices; Pharmaceutical', 'Part of Speech' => 'noun', 'Product Category' => 'Clinical trials', 'Creation User' => 'elighy', 'Creation Date' => '2012/10/13', 'Term' => 'investigational new drug', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'investigational_new_drug_₁', ))

stdClass::__set_state(array( 'id' => '7745593', 'url' => 'FR/study_coordinator', 'image' => '', 'title' => 'Coordinateur de l\'étude clinique', 'tags' => array ( 0 => 'Coordinateur de l\'étude clinique', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Coordinateur de l\'étude clinique', 'source_id' => 1259718, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20150721084111', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Un membre du personnel qui, travaillant pour l\'investigateur principal, contacte les patients par rapport à l\'inscription à l\'étude, planifie les rendez-vous, maintient les registres nécessaires et gère le fonctionnement quotidien de l\'étude.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507294573052821504, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Term' => 'study coordinator', 'Definition' => 'A staff person who works for the principal investigator to contact patients about enrolling in the study, schedule appointments, maintain required records and manage the day-to-day operation of the study.', 'Part of Speech' => 'noun', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Creation User' => 'John Martin', 'Creation Date' => '2011/5/16', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'study_coordinator', ))

stdClass::__set_state(array( 'id' => '10479592', 'url' => 'FR/amino_acids_₁₂', 'image' => '', 'title' => 'Acides aminés', 'tags' => array ( 0 => 'Acides aminés', 1 => 'Beauty', 2 => 'Skin care', 3 => '', ), 'term' => 'Acides aminés', 'source_id' => 5094749, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Beauty', ), 'category' => array ( 0 => 'Skin care', ), 'lastedit' => '20150728083421', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Les blocs de construction des protéines qui composent collagène et d\'élastine-substances qui donnent à la peau son soutien structurel. Le vieillissement et une combinaison de facteurs externes (dont la lumière UV et les toxines environnementales) réduisent le niveau des acides aminés dans le corps ; les crèmes contenant des acides aminés peuvent aider à les restaurer.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507928310838984707, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Definition' => 'The building blocks of the proteins that make up collagen and elastin—substances that give the skin its structural support. Aging and a combination of external factors (including UV light and environmental toxins) reduce the level of amino acids in the body; creams containing amino acids may help restore them.', 'Part of Speech' => 'noun', 'Industry' => 'Beauty', 'Product Category' => 'Skin care', 'Creation User' => 'MaryK', 'Creation Date' => '2013/3/16', 'Term' => 'amino acids', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'amino_acids_₁₂', ))

stdClass::__set_state(array( 'id' => '6230216', 'url' => 'FR/primary_purpose', 'image' => '', 'title' => 'Objectif principal', 'tags' => array ( 0 => 'Objectif principal', 1 => 'Medical devices', 2 => 'Pharmaceutical', 3 => 'Clinical trials', 4 => 'National Library of Medicine', 5 => '', ), 'term' => 'Objectif principal', 'source_id' => 4011788, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Medical devices', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'company' => array ( 0 => 'National Library of Medicine', ), 'lastedit' => '20150727104714', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'L\'une des raisons principales de l\'essai clinique. Les types d\'objectifs principaux incluent le traitement, la prévention, le diagnostic, les soins de soutien, le dépistage, la recherche sur les services de santé, et la science de base.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507846081755480065, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Company' => 'National Library of Medicine', 'Definition' => 'The one main reason for the clinical trial. Types of primary purposes include treatment, prevention, diagnostic, supportive care, screening, health services research, and basic science.', 'Industry' => 'Medical devices; Pharmaceutical', 'Part of Speech' => 'noun', 'Product Category' => 'Clinical trials', 'Creation User' => 'elighy', 'Creation Date' => '2012/10/13', 'Term' => 'primary purpose', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'primary_purpose', ))

stdClass::__set_state(array( 'id' => '6229325', 'url' => 'FR/informed_consent_₁₂', 'image' => '', 'title' => 'Consentement éclairé', 'tags' => array ( 0 => 'Consentement éclairé', 1 => 'Medical devices', 2 => 'Pharmaceutical', 3 => 'Clinical trials', 4 => 'National Library of Medicine', 5 => '', ), 'term' => 'Consentement éclairé', 'source_id' => 4011444, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Medical devices', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'company' => array ( 0 => 'National Library of Medicine', ), 'lastedit' => '20150727104711', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Un processus dans lequel les chercheurs communiquent avec les participants potentiels et inscrits dans une étude clinique. Ceci est lorsque les chercheurs : # fournissent toutes les informations importantes concernant l\'étude, de sorte que les participants potentiels peuvent décider de s\'y inscrire (ou si elles sont inscrites, de continuer à participer) ; # s\'assurent que les participants potentiels comprennent les risques et les bénéfices potentiels de participer à l\'étude, et les alternatives à l\'étude conduite ; et # soulignent que l\'inscription à une étude clinique (et de rester dedans) est entièrement volontaire. Parce que donner son consentement pour participer à la recherche n\'est pas un contrat, les participants peuvent quitter une étude à tout moment. Le but du processus de consentement éclairé est de protéger les participants. Il commence quand un participant potentiel demande au début des informations sur une étude et continue tout au long de l\'étude jusqu\'à ce que l\'étude se termine. Le chercheur et le participant potentiel ont des discussions qui incluent de répondre aux questions des participants sur la recherche. Toutes les informations importantes à propos de l\'étude doivent également être remises au participant potentiel dans un document écrit qui est clair et facile à comprendre. Ce document de consentement éclairé est examiné et approuvé par le Comité de protection des personnes pour chaque étude avant d\'être remis aux participants potentiels. Généralement, une personne doit signer un document de consentement éclairé pour s\'inscrire dans une étude.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507846081754431490, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Company' => 'National Library of Medicine', 'Definition' => 'A process in which researchers communicate with potential and enrolled participants about a clinical study. This is when researchers: # provide all the important information about the study, so that potential participants can decide whether to enroll (or if enrolled, to continue participating); # ensure that potential participants understand the risks and potential benefits of participating in the study, and the alternatives to the research being conducted; and # stress that enrolling in (and staying in) a clinical study is completely voluntary. Because giving consent to participate in research is not a contract, participants can leave a study at any time. The goal of the informed consent process is to protect participants. It begins when a potential participant first asks for information about a study and continues throughout the study until the study ends. The researcher and potential participant have discussions that include answering the participant\'s questions about the research. All the important information about the study must also be given to the potential participant in a written document that is clear and easy to understand. This informed consent document is reviewed and approved by the human subjects review board for a study before it is given to potential participants. Generally, a person must sign an informed consent document to enroll in a study.', 'Industry' => 'Medical devices; Pharmaceutical', 'Part of Speech' => 'noun', 'Product Category' => 'Clinical trials', 'Creation User' => 'elighy', 'Creation Date' => '2012/10/13', 'Term' => 'informed consent', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'informed_consent_₁₂', ))

stdClass::__set_state(array( 'id' => '10479588', 'url' => 'FR/Dermokil', 'image' => 'dermokillogo-1359898176.jpg;', 'title' => 'Dermokil', 'tags' => array ( 0 => 'Dermokil', 1 => 'Beauty', 2 => 'Skin care', 3 => '', ), 'term' => 'Dermokil', 'source_id' => 4925105, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Beauty', ), 'category' => array ( 0 => 'Skin care', ), 'lastedit' => '20150728083408', 'part_of_speech' => 'proper noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Ezel Kozmetik a été fondée suite à une décision prise par l’homme d’affaire Ünal Karaca après avoir vu que l’on pouvait concevoir des produits cosmétiques à partir de sel de la mer Morte. Sur ce, il décida de produire des produits à base d\'argile qui sont utilisés depuis des siècles en Anatolie et plus récemment partout dans le monde et de promouvoir ses avantages en tant que produits cosmétiques. Les produits Dermokil (Produits Dermoclay) ont vu le jour à l’issue de 2 ans d’étude dans les laboratoires R&D et après les résultats positifs obtenus lors des essais effectués sur 2000 personnes. Les certificats d’enregistrement de marque et les rapports d’approbation établis par l’université Cumhuriyet, les matières premières et les produits ayant des rapports d’analyse microbiologique sont contrôlés par des dispositifs technologiques conformément aux normes nationales et internationales. Les analyses physiques, chimiques et microbiologiques des produits se réalisent d’une manière rapide et sûre à chaque étape de la production. L\'usine d\'Ezel Kozmetik composée d\'installations de production modernes a été établie à Sivas en 2006 et d\'une équipe de R&D composée d’ingénieurs chimistes experts en la matière, vise à devenir une marque leader dans le secteur de la cosmétique à travers ses machines de technologie avancée et son service logistique.', 'usage_comment' => '', 'glossary' => '', 'width' => 300, 'height' => 300, '_version_' => 1507928310837936128, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Term' => 'Dermokil', 'Definition' => 'Ezel Kozmetik was founded when Unal Karaca, the businessman, saw that the cosmetic products were made up of the salt of the Dead Sea and decided to produce the clay products which have been used in Anatolia for centuries and throughout the world during the recent years and to promote its benefits as a cosmetics. The Dermokil products (Dermoclay Products) appeared after testing on 2000 individuals and obtaining positive results and a two-year R&D study. Its brand registration certificates and the reports approved by Cumhuriyet University, the raw materials and products having microbiological analysis report are inspected by technological devices in national and international standards. In every stage of the production, the physical, chemical and microbiological analyses of the products are rapidly and reliably conducted. The factory of Ezel Kozmetik composed of the modern manufacturing plant established in Sivas in 2006 and an R&D team consisting of chemical engineers who are expert in their field aims to go ahead on the road to become a pioneer brand in the cosmetics sector through the high-tech machines and logistics services it provides.', 'Part of Speech' => 'proper noun', 'Usage Status' => 'New', 'Sample Image' => 'dermokillogo-1359898176.jpg;', 'Industry' => 'Beauty', 'Product Category' => 'Skin care', 'Creation User' => 'dermokil', 'Creation Date' => '2013/2/5', 'Company' => '', 'Synonym' => '', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Dermokil', ))

stdClass::__set_state(array( 'id' => '6229990', 'url' => 'FR/other_adverse_event', 'image' => '', 'title' => 'Autre événement indésirable', 'tags' => array ( 0 => 'Autre événement indésirable', 1 => 'Medical devices', 2 => 'Pharmaceutical', 3 => 'Clinical trials', 4 => 'National Library of Medicine', 5 => '', ), 'term' => 'Autre événement indésirable', 'source_id' => 4011599, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Medical devices', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'company' => array ( 0 => 'National Library of Medicine', ), 'lastedit' => '20150722110608', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Un événement indésirable qui n\'est pas un événement indésirable grave.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507394292252934144, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Company' => 'National Library of Medicine', 'Definition' => 'An adverse event that is not a serious adverse event.', 'Industry' => 'Medical devices; Pharmaceutical', 'Part of Speech' => 'noun', 'Product Category' => 'Clinical trials', 'Creation User' => 'elighy', 'Creation Date' => '2012/10/13', 'Term' => 'other adverse event', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'other_adverse_event', ))